Mobile Menu - OpenMobile Menu - Closed

Hearing on "Pathway to Protection: Expanding Availability of COVID-19 Vaccines"

Date: 
Tuesday, February 23, 2021 - 10:30am
Location: 
Virtual Hearing via Cisco WebEx

The Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce held a hearing on Tuesday, February 23, 2021, at 10:30 a.m. via Cisco WebEx. The hearing is entitled, "Pathway to Protection: Expanding Availability of COVID-19 Vaccines."

 

Key Documents

 

Memorandum from Chairman Pallone to the Subcommittee on Oversight and Investigations

Opening Statement from Chairman Pallone as prepared for delivery

Opening Statement from Subcommittee Chair DeGette as prepared for delivery

 

Livestream

 

 

Witnesses

 

John Young
Group President, Chief Business Officer
Pfizer

Testimony

 

 

Stephen Hoge, M.D.
President
Moderna

Testimony

 

 

Richard Nettles, M.D. 
Vice President of Medical Affairs, Janssen Pharmaceutical Companies
Johnson & Johnson

Testimony

 

 

Ruud Dobber, Ph.D.
Executive Vice President and President, BioPharmaceuticals Business Unit
AstraZeneca

Testimony

 

 

John Trizzino
Executive Vice President, Chief Commercial Officer, and Chief Business Officer
Novavax, Inc.

Testimony

 

 

Issues: